Angelo Zanniti/LinkedIn
Jun 15, 2026, 13:05
Angelo Zanniti: Back from EHA 2026 Congress
Angelo Zanniti, Medical Biotechnologist at CEINGE Official Profile, shared a post on LinkedIn:
“Back from an inspiring few days at the EHA 2026 Congress in Stockholm.
It was a great opportunity to connect with colleagues, share experiences, and discover the latest advances in hematology and molecular diagnostics.
Conferences like these remind us how quickly our field is evolving and how important collaboration is in driving innovation and improving patient care.
Grateful for the experience and looking forward to putting new ideas into practice.”
Stay updated with Hemostasis Today.
-
Sep 18, 2026, 01:35Matthew Hazell: From Platelet Refractoriness to Protecting Transplanted Organs
-
Sep 18, 2026, 01:23Apple Joy A. Valenzuela: Exploring How Neutrophil Develops from the Myeloblast to the Mature Segmented Neutrophil
-
Sep 18, 2026, 01:13Su Someh: Gaps and Variation in Global Plasma Donor Protection Policies
-
Sep 18, 2026, 01:03Joseph R. Shaw: Study Questions Blanket “No-Bridging” Strategy for Mechanical Heart Valves
-
Sep 17, 2026, 20:38Konstantinos Bistas: Reduced Circulating Tregs in Pediatric Chronic Neutropenia
-
Sep 17, 2026, 15:33Gopal Patidar: Honoured to Contribute to the ASFA 2026 Guidelines for Therapeutic Apheresis
-
Sep 17, 2026, 20:36Cosima C. Hoch: Developing a 3D Organotypic Co-Culture Model for Pleomorphic Adenoma
-
Sep 17, 2026, 20:19Riten Kumar: Boston Children’s Hospital Ranked No. 1 in Seven Pediatric Specialties
-
Sep 17, 2026, 20:17Katrina Snow: Whole Blood or Component Therapy – Which Would You Choose?